IO Biotech Inc. (NASDAQ: IOBT) Stock Information | RedChip

IO Biotech Inc. (NASDAQ: IOBT) Listen to this Section


$1.39
+0.0400 ( +2.96% ) 76.2K

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Market Data


Open


$1.39

Previous close


$1.35

Volume


76.2K

Market cap


$92.23M

Day range


$1.35 - $1.45

52 week range


$0.82 - $2.12

Insider Ownership Transactions

Total Amount Purchased: -2,014,183.00 | $ -2,799,714.37

Date Type Amount Purchased Purchaser
2024-07-26 Sale -51522.00 Novo Holdings A/S
2024-06-07 Sale -45642.00 Hunter Heidi
2024-06-07 Sale -45642.00 Glaub Kathleen Sereda
2024-06-07 Sale -45642.00 Elling Christian E
2024-06-07 Sale -45642.00 Collins Helen Louise
2024-06-07 Sale -45642.00 Hirth Peter
2024-06-07 Sale -45642.00 Smith David V
2024-05-14 Sale -658809.00 Novo Holdings A/S
2024-03-18 Sale -750000.00 Zocca Mai-Britt
2024-03-18 Sale -280000.00 Sullivan Amy

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 64 Aug 13, 2024
8-k 8K-related 15 Aug 13, 2024
4 Insider transactions 1 Jul 26, 2024
8-k 8K-related 13 Jun 11, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.